Director, Medical Clinical Evidence Implementation Liaison - Respiratory / Emerging Areas

Boehringer Ingelheim; Ridgefield (CT); In loco; USD 180.000 - 280.000; Tempo pieno

Descrizione del lavoro

Boehringer Ingelheim seeks a Director of Clinical Evidence Implementation Liaisons to lead a field-based CEIL team delivering focused medical engagement across prioritized therapeutic areas, assets, and organized accounts including health systems and payers. You will translate TA and asset strategies into prioritized engagement plans and drive science-based opportunities that improve patient outcomes.

As a strategic leader, you will coach the team to build trusted relationships with

Mansioni

• Translate approved Medicine, TA, and asset strategies into a clear CEIL engagement strategy, operating priorities, and execution expectations across assigned health-system and payer segments.
• Set standards and provide oversight for high-quality, compliant scientific exchange and account medical leadership across prioritized organized customers.
• Build team capability and establish a consistent approach for CEIL execution, coaching, and governance of interventions.

Descrizione del lavoro

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, mobility, networking and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.

The Director, Clinical Evidence Implementation Liaisons (CEILs), leads and develops a field-based team of Clinical Evidence Implementation Liaisons responsible for delivering focused medical engagement across prioritized therapeutic areas, assets, and organized customer accounts, including health systems, integrated delivery networks, payers, pharmacy benefit managers, and other organizations influencing population-based care. The Director translates approved TA and asset strategies into clear account priorities, portfolio decisions, and execution expectations; ensures CEILs build trusted scientific relationships, generate actionable account insights, and identify care-delivery, evidence-generation, quality-improvement, and Implementation Science opportunities with the potential for measurable patient and health-system impact. The role provides strategic and people leadership for the CEIL team by establishing consistent standards for account prioritization, scientific exchange, opportunity qualification, intervention execution, insight generation, and cross-functional collaboration. In partnership with CEIL leadership, TA/CDMA, the Implementation Science team, and relevant account partners, the Director evaluates emerging opportunities, governs deployment of team capacity and resources, supports execution of approved interventions, and escalates material portfolio or investment decisions through established governance. Through active field coaching, performance management, and continuous improvement, the Director builds team capability, reinforces compliant and ethical decision-making, and evolves the CEIL operating model in response to changing healthcare-system needs while maintaining alignment with Medicine strategy.

Description

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, mobility, networking and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.

The Director, Clinical Evidence Implementation Liaisons (CEILs), leads and develops a field-based team of Clinical Evidence Implementation Liaisons responsible for delivering focused medical engagement across prioritized therapeutic areas, assets, and organized customer accounts, including health systems, integrated delivery networks, payers, pharmacy benefit managers, and other organizations influencing population-based care. The Director translates approved TA and asset strategies into clear account priorities, portfolio decisions, and execution expectations; ensures CEILs build trusted scientific relationships, generate actionable account insights, and identify care-delivery, evidence-generation, quality-improvement, and Implementation Science opportunities with the potential for measurable patient and health-system impact. The role provides strategic and people leadership for the CEIL team by establishing consistent standards for account prioritization, scientific exchange, opportunity qualification, intervention execution, insight generation, and cross-functional collaboration. In partnership with CEIL leadership, TA/CDMA, the Implementation Science team, and relevant account partners, the Director evaluates emerging opportunities, governs deployment of team capacity and resources, supports execution of approved interventions, and escalates material portfolio or investment decisions through established governance. Through active field coaching, performance management, and continuous improvement, the Director builds team capability, reinforces compliant and ethical decision-making, and evolves the CEIL operating model in response to changing healthcare-system needs while maintaining alignment with Medicine strategy.

Duties & Responsibilities

CEIL Strategy, Portfolio Prioritization, and Resource Leadership

Translate approved Medicine, TA, and asset strategies into a clear CEIL engagement strategy, operating priorities, and execution expectations across assigned health-system and payer segments. Establish and apply consistent criteria for account prioritization, account assignment, stakeholder focus, and deployment of team capacity. Review emerging opportunities and changing account conditions; make evidence-based recommendations to continue, expand, modify, replace, or deprioritize account activity, while escalating material investment decisions through established governance.

Scientific Engagement and Account Medical Leadership

Set standards and provide oversight for high-quality, compliant scientific exchange and account medical leadership across prioritized organized customers. Ensure Clinical Evidence Implementation Liaisons develop trusted relationships with relevant scientific, clinical, quality, pharmacy, informatics, care- coordination, and executive stakeholders; understand account decision-making and evidence needs; and contribute appropriately to integrated account planning. Resolve role-boundary or coordination issues and strengthen collaboration across CEIL, TA/CDMA, MSL, market access, account, and other relevant partners.

Care- Gap, Patient-Journey, and Implementation Science Opportunity Leadership

Build team capability and establish a consistent approach for